In presenting this Award, Frost & Sullivan commends the company for having distinguished itself in the market with the successful launch of the XTRM-WAY PTCA dilatation catheter in 2006.
“The XTRM WAY PTCA dilatation catheter is a first-of-its-kind product based on an innovative technology,” notes Frost & Sullivan Research Analyst Ms. Sowmya Rajagopalan. “It is likely to set the stage for a revolution in percutaneous transluminal coronary angioplasty (PTCA) catheters in the future.”
Founded in 1998, Blue Medical Devices B.V. focuses on cardiology and minimally invasive surgeries. It offers a wide range of products in the field of cardiology, including stents, balloons and catheters. Owing to its continued efforts in developing new technologies and products, the company holds a number of patents in the cardiology market.
With R&D being a key focus area, Blue Medical has several technologies patented and exclusively licensed in the stents and drug eluting stents field, such as the Melissa and PolyEsterAmide (PEA) bio-absorbable coatings for stents, among others. The company’s focus on research in stents has played an important role in the development of the revolutionising Checker technology, upon which the XTRM-WAY PTCA dilatation catheter is based.
“This product is a result of extensive research by the company,” states Ms. Rajagopalan. “Owing to findings that the flexibility of the balloon on stent delivery catheters is higher in comparison to the normal PTCA catheter, BlueMedical created the XTRM-WAY PTCA dilatation catheter to develop higher flexibility in the balloon segment.”
The patented Checker technology helps in enhancing balloon-crossing performance. It has one of the least crossing profiles in balloons and reveals that balloon-crossing profiles are reduced by 15 per cent in comparison to standard balloons. As a result, the need for pre-dilatation of the vessel to allow the catheter to pass through is reduced and it also produces highly flexible balloons, which are crucial in angioplasty.
Another advantage of the product is the limited risk of balloon slippage during inflation due to the Checker Technology even though the balloon has a hydrophilic coating. The Checker technology has also given Blue Medical an edge to enter into the CTO segment by adding a first to the market 1.1 mm PTCA balloon catheter into the product portfolio.
“The XTRM-WAY catheters are sold exclusively by the company, which has a well-developed network of distributors,” remarks Ms. Rajagopalan. “Its established relationship with decision makers in hospitals, physicians and other small participants has assisted in increasing the market for the product.”
“We are pleased to receive this recognition for all the hard work our team has put into bringing the Checker and other technologies to the market place.” said Ronald Horvers, Blue Medical’s CEO. “This prestigious award is a true sign that our passion for innovation and patient care is recognized also by others than the direct users of our products and will certainly help Blue Medical in taking the next steps in becoming a true world wide player in this field”
The Frost & Sullivan Award for Product Innovation is presented each year to the company that has demonstrated excellence in new products and technologies within their industry. The recipient company has shown innovation by launching a broad line of emerging products and technologies.
Frost & Sullivan Best Practices Awards recognise companies in a variety of regional and global markets for demonstrating outstanding achievement and superior performance in areas such as leadership, technological innovation, customer service, and strategic product development. Industry analysts compare market participants and measure performance through in-depth interviews, analysis, and extensive secondary research in order to identify best practices in the industry.
About Blue Medical
Blue Medical Devices BV (bluemedical.com) is a medical devices company with focus on cardiology and minimally invasive surgeries. It was founded in 1998, with its headquarters in the Netherlands. It offers a wide range of products in the field of cardiology, including stents, balloons and catheters. The company’s proactive effort in developing innovative technology and products has paid significant dividends in terms of revenues. Owing to its continued efforts in developing new technologies and products, the company holds a number of patents and exclusive licenses in the cardiology market.
About Frost & Sullivan
Frost & Sullivan, a global growth consulting company, has been partnering with clients to support the development of innovative strategies for more than 40 years. The company's industry expertise integrates growth consulting, growth partnership services, and corporate management training to identify and develop opportunities. Frost & Sullivan serves an extensive clientele that includes Global 1000 companies, emerging companies, and the investment community by providing comprehensive industry coverage that reflects a unique global perspective and combines ongoing analysis of markets, technologies, econometrics, and demographics.
For further information, please contact:
Mr. Joakim Eriksson,
Executive VP Sales and Marketing / Business Development
T: +31 492 588 900